Detalhe da pesquisa
1.
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19.
Am J Respir Crit Care Med
; 205(5): 507-519, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878969
2.
HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer.
Sci Adv
; 9(11): eadd3243, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36930718
3.
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers.
Science
; 381(6657): 515-524, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535729
4.
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients.
Cell Rep Med
; 3(10): 100779, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208629
5.
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.
Cell Rep Med
; 3(2): 100500, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243413
6.
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients.
bioRxiv
; 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642692
7.
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.
J Clin Invest
; 131(13)2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196300
8.
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes.
medRxiv
; 2021 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655257
9.
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.
Sci Immunol
; 6(64): eabj2901, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34652962
10.
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions.
Cell Rep Med
; 2(5): 100287, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969320
11.
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients.
bioRxiv
; 2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173871
12.
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer.
Cancer Discov
; 9(5): 605-616, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30877085